US Patent Issued to Federico Amezcua Amezcua on May 6 for "Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses" (Mexican Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,526, issued on May 6, was assigned to Federico Amezcua Amezcua (Jalisco, Mexico).

"Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses" was invented by Patricia Del Carmen Garcia Armenta (Jalisco, Mexico).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention is related to a pharmaceutical composition made up by the synergic combination of a nonsteroidal anti-inflammatory analgesic such as Aceclofenac or its pharmaceutically acceptable salts and an anti-inflammatory steroid agent such as the active ingredient Betamethasone or its pharmaceutically ac...